StORMM: Study of Ocean Rowing Muscle Metabolism. 1. What Effect Does Rowing 3000 Miles Across Atlantic Ocean Have on Calf Muscle Size? 2. In the Catabolic State of Extreme Endurance, is Muscle Loss Uniform or Can the Human Body Select Depending on Load and Nutrient Availability?

Sponsor
University of Exeter (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05729841
Collaborator
(none)
60
1
36.1
1.7

Study Details

Study Description

Brief Summary

Little is known on the human adaptation to extreme endurance and with the increasing popularity in long duration events we seek to provide insight into the physiological and metabolic adaptation processes of ocean rowing.

Rowing 12-18 hours a day will illicit a high energy expenditure and anecdotally people have lost large amounts of body weight and variable amounts of muscle mass, particularly in the lower limbs. This may provide insights and a potential new model to to study muscle unloading.

Condition or Disease Intervention/Treatment Phase
  • Other: Ocean row

Detailed Description

Previous research has investigated factors determining muscle loss through bed rest and limb immobilisation. These methods are limited in that some do not include inflammation or changes in nutrition, which have been shown to be key drivers of muscle loss. These studies aim to investigate a potentially new model of muscle unloading.

Ocean rowing is an ultra-endurance sport where people spend 35-90 days at sea. Usually rowing for a minimum of 12 hours a day, in a 2-hour on/off shift pattern with daily food rations. Rowers lose body and muscle mass. There is likely to be low-grade inflammation, nutritional deficit, fatigue and rowers do not stand up for the entire crossing. Part 1 aims to quantify this muscle loss by inviting rowers in the annual 3000 mile Talisker Whisky Atlantic Challenge 2020 to take part. While part 2 aims to continue the work by measuring upper and core muscles as well as lower limb muscles from the first study with the aim of understanding how the body allocates resources in a hypocaloric, high energy expenditure environment.

Muscle mass of the lower limbs of the rowers will be measured with ultrasound, as well as body mass, body composition, energy expenditure and nutritional intake, the week before the race and immediately after arrival in Antigua. As well as adding novel insights to the knowledge base around factors affecting ultra endurance performance, the results will then be used to inform future intervention studies aimed at preventing muscle loss.

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
StORMM 1:What Effect Does Rowing 3000 Miles Across Atlantic Ocean Have on Calf Muscle Size? StORMM 2. In the Catabolic State of Extreme Endurance, is Muscle Loss Uniform or Can the Human Body Select Depending on Load and Nutrient Availability?
Actual Study Start Date :
Nov 28, 2020
Actual Primary Completion Date :
Feb 16, 2022
Anticipated Study Completion Date :
Dec 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Energy Expenditure [5-7 days in final week of row]

    Amount of kcals expended per day

  2. Calf Muscle thickness [5-7 weeks]

    Pre - Post measurements of calf muscle thickness

  3. Energy Intake [5-7 days in final week of row]

    Amount of kcals consumed per day

Secondary Outcome Measures

  1. Difference in rate of muscle thickness loss between males and females [5-7 weeks]

    Absolute and relative differences in energy balance, body mass loss or muscle loss

  2. Difference in rate of muscle thickness loss in older vs younger rowers [5-7 weeks]

    Are there any age-related differences in energy balance, body mass loss or muscle loss

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Taking part in the Talisker Whisky Atlantic Challenge 2020 and 2021
Exclusion Criteria:
  • lower limb amputee musculoskeletal, metabolic, neurological disease pacemaker fitted

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Exeter Exeter Devon United Kingdom EX2 4TH

Sponsors and Collaborators

  • University of Exeter

Investigators

  • Principal Investigator: Francis Stephens, University of Exeter

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Exeter
ClinicalTrials.gov Identifier:
NCT05729841
Other Study ID Numbers:
  • 201021-A-08
First Posted:
Feb 15, 2023
Last Update Posted:
Feb 15, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Exeter

Study Results

No Results Posted as of Feb 15, 2023